Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 27,500 shares at $27.00 ($741K) on 2009-09-14, disclosed to the SEC on 2009-09-15.
Open-market sale of $741k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.30 | 4,000 | $101K | 13.7% |
| 2 | $25.40 | 2,020 | $51K | 6.9% |
| 3 | $26.72 | 5,480 | $146K | 19.8% |
| 4 | $27.00 | 6,000 | $162K | 21.9% |
| 5 | $27.65 | 5,000 | $138K | 18.7% |
| 6 | $28.28 | 5,000 |
| $141K |
| 19.1% |
| Total | $26.93 avg | 27,500 | $741K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |